These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

136 related articles for article (PubMed ID: 28926893)

  • 1. [Effect of intratumor heterogeneity of esophageal squamous cell carcinoma on chemotherapy sensitivity].
    Sun L; Wu W; Yan M; Han PL; Zhan X; Ma XW; Cao XG; Zhao S; Gao F; Qi Y; Cao W
    Zhonghua Zhong Liu Za Zhi; 2017 Sep; 39(9):657-663. PubMed ID: 28926893
    [No Abstract]   [Full Text] [Related]  

  • 2. Krüppel-Like Factor 4 Enhances Sensitivity of Cisplatin to Esophageal Squamous Cell Carcinoma (ESCC) Cells.
    Chen C; Ma Z; Zhang H; Liu X; Yu Z
    Med Sci Monit; 2017 Jul; 23():3353-3359. PubMed ID: 28694421
    [TBL] [Abstract][Full Text] [Related]  

  • 3. MiR-495 Inhibits Cisplatin Resistance and Angiogenesis in Esophageal Cancer by Targeting ATP7A.
    Li Z; Li S; Wen Y; Chen J; Liu K; Jia J
    Technol Cancer Res Treat; 2021; 20():15330338211039127. PubMed ID: 34747666
    [No Abstract]   [Full Text] [Related]  

  • 4. Nimotuzumab with cisplatin or fluorouracil on human esophageal squamous cell carcinoma EC1 cells.
    Ji YH; Yang XY; Wu JQ; Huo XQ; Li WW; Li GJ; Mu YL; Lu P
    Eur Rev Med Pharmacol Sci; 2015 Feb; 19(4):586-91. PubMed ID: 25753875
    [TBL] [Abstract][Full Text] [Related]  

  • 5. RIPK1 contributes to cisplatin-induced apoptosis of esophageal squamous cell carcinoma cells via activation of JNK pathway.
    Zhang Y; Du J; Duan X; Peng W; Lv L; Chen Z; Zhang Y
    Life Sci; 2021 Mar; 269():119064. PubMed ID: 33460665
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Upregulation of KCNMA1 facilitates the reversal effect of verapamil on the chemoresistance to cisplatin of esophageal squamous cell carcinoma cells.
    Ge N; Yang GS; Zhang TY; Chang N; Kang YH; Zhou Q; Fan PS
    Eur Rev Med Pharmacol Sci; 2021 Feb; 25(4):1869-1880. PubMed ID: 33660797
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Knockdown of frizzled-7 inhibits cell growth and metastasis and promotes chemosensitivity of esophageal squamous cell carcinoma cells by inhibiting Wnt signaling.
    Liu X; Yan Y; Ma W; Wu S
    Biochem Biophys Res Commun; 2017 Aug; 490(3):1112-1118. PubMed ID: 28669726
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effect of hOGG1 over-expression on cisplatin resistance in esophageal squamous carcinoma cells.
    Gao D; Hu J; Zhang X; Gao C; Hong J
    Cancer Biother Radiopharm; 2013; 28(6):433-40. PubMed ID: 23806019
    [TBL] [Abstract][Full Text] [Related]  

  • 9. TNF‑α‑mediated upregulation of SOD‑2 contributes to cell proliferation and cisplatin resistance in esophageal squamous cell carcinoma.
    Zuo J; Zhao M; Liu B; Han X; Li Y; Wang W; Zhang Q; Lv P; Xing L; Shen H; Zhang X
    Oncol Rep; 2019 Oct; 42(4):1497-1506. PubMed ID: 31364751
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Sirtuin1 (sirt1) regulates the glycolysis pathway and decreases cisplatin chemotherapeutic sensitivity to esophageal squamous cell carcinoma.
    Yang X; Li S; Xu C; Liu S; Zhang X; Lian B; Li M
    Cancer Biol Ther; 2024 Dec; 25(1):2365449. PubMed ID: 38865161
    [TBL] [Abstract][Full Text] [Related]  

  • 11. RUNX3 reverses cisplatin resistance in esophageal squamous cell carcinoma via suppression of the protein kinase B pathway.
    Li DJ; Shi M; Wang Z
    Thorac Cancer; 2016 Sep; 7(5):570-580. PubMed ID: 27766776
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comparison of neoadjuvant chemotherapy versus upfront surgery with or without chemotherapy for patients with clinical stage III esophageal squamous cell carcinoma.
    Matsuda S; Tsubosa Y; Sato H; Takebayashi K; Kawamorita K; Mori K; Niihara M; Tsushima T; Yokota T; Onozawa Y; Yasui H; Takeuchi H; Kitagawa Y
    Dis Esophagus; 2017 Feb; 30(2):1-8. PubMed ID: 26919154
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Corilagin Inhibits Esophageal Squamous Cell Carcinoma by Inducing DNA Damage and Down-Regulation of RNF8.
    Qiu F; Liu L; Lin Y; Yang Z; Qiu F
    Anticancer Agents Med Chem; 2019; 19(8):1021-1028. PubMed ID: 30848215
    [TBL] [Abstract][Full Text] [Related]  

  • 14. ATG7 deficiency promote apoptotic death induced by Cisplatin in human esophageal squamous cell carcinoma cells.
    Zhu L; Du H; Shi M; Chen Z; Hang J
    Bull Cancer; 2013; 100(7-8):15-21. PubMed ID: 23823853
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prognostic relevance and therapeutic implications of centromere protein F expression in patients with esophageal squamous cell carcinoma.
    Mi YJ; Gao J; Xie JD; Cao JY; Cui SX; Gao HJ; Yao SP; Liu T; Zhang YY; Guo CH; Qiu GQ; Chen YQ
    Dis Esophagus; 2013 Aug; 26(6):636-43. PubMed ID: 23163484
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Targeting MCL-1 sensitizes human esophageal squamous cell carcinoma cells to cisplatin-induced apoptosis.
    Yu X; Li W; Xia Z; Xie L; Ma X; Liang Q; Liu L; Wang J; Zhou X; Yang Y; Liu H
    BMC Cancer; 2017 Jun; 17(1):449. PubMed ID: 28659182
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A dual mTORC1 and mTORC2 inhibitor shows antitumor activity in esophageal squamous cell carcinoma cells and sensitizes them to cisplatin.
    Huang Y; Xi Q; Chen Y; Wang J; Peng P; Xia S; Yu S
    Anticancer Drugs; 2013 Oct; 24(9):889-98. PubMed ID: 23838676
    [TBL] [Abstract][Full Text] [Related]  

  • 18. HNRNPUL1 inhibits cisplatin sensitivity of esophageal squamous cell carcinoma through regulating the formation of circMAN1A2.
    Li J; Sang M; Zheng Y; Meng L; Gu L; Li Z; Liu F; Wu Y; Li W; Shan B
    Exp Cell Res; 2021 Dec; 409(1):112891. PubMed ID: 34688610
    [TBL] [Abstract][Full Text] [Related]  

  • 19. P21-activated kinase 7 mediates cisplatin-resistance of esophageal squamous carcinoma cells with Aurora-A overexpression.
    He S; Feng M; Liu M; Yang S; Yan S; Zhang W; Wang Z; Hu C; Xu Q; Chen L; Zhu H; Xu N
    PLoS One; 2014; 9(12):e113989. PubMed ID: 25436453
    [TBL] [Abstract][Full Text] [Related]  

  • 20. MicroRNA-125a-5p enhances the sensitivity of esophageal squamous cell carcinoma cells to cisplatin by suppressing the activation of the STAT3 signaling pathway.
    Zhao Y; Ma K; Yang S; Zhang X; Wang F; Zhang X; Liu H; Fan Q
    Int J Oncol; 2018 Aug; 53(2):644-658. PubMed ID: 29767234
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.